Logo for Ondine Biomedical Inc

Ondine Biomedical Investor Relations Material

Latest events

Logo for Ondine Biomedical Inc

H1 2024

Ondine Biomedical
Logo for Ondine Biomedical

H1 2024

30 Sep, 2024
Logo for Ondine Biomedical

H2 2023

10 Jun, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Ondine Biomedical Inc

Access all reports
Ondine Biomedical Inc. is a life sciences company specializing in the development of photodisinfection-based therapies. These innovative therapies are designed to provide solutions for a wide range of infections, including those resistant to antibiotics. The company's focus is on creating non-antibiotic anti-infective treatments for bacterial, viral, and fungal infections, leveraging its patented light-activated technology. Ondine Biomedical Inc.'s approach represents a significant advancement in addressing the global challenge of drug-resistant infections, offering potential benefits in both healthcare settings and beyond. The company is headquartered in Vancouver, Canada, and its shares are listed on the London Stock Exchange.